ArticleCancers2022

Clinical Outcomes in Fibrolamellar Hepatocellular Carcinoma Treated with Immune Checkpoint Inhibitors.

Krista Y Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.